Usefulness of a New Therapy Using Rebamipide Eyedrops in Patients with VKC/AKC Refractory to Conventional Anti-Allergic Treatments

Usefulness of a New Therapy Using Rebamipide Eyedrops in Patients with VKC/AKC Refractory to Conventional Anti-Allergic Treatments

Background: Rebamipide, a gastroprotective drug, has been reported to suppress gastric mucosal inflammation. In Japan, rebamipide eyedrops have recently been approved for the treatment of dry eye disease. Some patients with allergic conjunctival diseases such as vernal keratoconjunctivitis (VKC) or...

Full description

Bibliographic Details
Main Authors: Mayumi Ueta, Chie Sotozono, Ayaka Koga, Norihiko Yokoi, Shigeru Kinoshita
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Allergology International
Subjects:
allergic conjunctivitis
atopy
dry eye with decreased tear break-up time
giant papilla
rebamipide
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015300113

Internet

http://www.sciencedirect.com/science/article/pii/S1323893015300113

Similar Items